"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell ...

She now coaches at Precision Gymnastics Academy in Albuquerque. Little did she know, it's inside that gym where she would meet someone who she would need later down the road. Sign up for our ...

Medics have issued a warning about a little-known change to your fingertips which could be an early indication of cancer.

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

I never thought in a million years that this would happen to me … especially so young,” Brooklynite Jaclyn Keely told The ...

Ideaya Biosciences, Inc. progresses trials for uveal melanoma and solid tumors, with key upcoming data milestones. Click for ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

Teos Therapeutics faces significant setbacks with the discontinuation of their TIGIT program and belrestotug, leaving them ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Incentivizing physicians with modest financial bonuses may seem like a small step, but in Japan’s outpatient oncology setting ...